Found 20 results
Author Title [ Type(Desc)] Year
Filters: Author is Bernstein, DI  [Clear All Filters]
Journal Article
R. B. Belshe, Heineman, T. C., Bernstein, D. I., Bellamy, A. R., Ewell, M., van der Most, R., and Deal, C. D., Correlate of Immune Protection Against HSV-1 Genital Disease in Vaccinated Women, J Infect Dis, vol. 209, pp. 828-836, 2014.
B. R. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Cho, I., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine, J Infec Dis, vol. 181, pp. 11133-7, 2000.
M. Rennels, Englund, J. A., Bernstein, D. I., Losonsky, G. A., Anderson, E. L., Pichichero, M. E., Munoz, F. M., and Wolff, M. C., Diminution of the Anti-PRP response to a combined DtaP/Hib vaccine by concurrent inactivated poliovirus vaccination, Ped J Infec Dis, vol. 19, pp. 417-23, 2000.
J. E. Ledgerwood, Bellamy, A. R., Belshe, R., Bernstein, D. I., Edupuganti, S., Patel, S. M., Renehan, P., Zajdowicz, T., Schwartz, R., Koup, R., Bailer, R. T., Yamshchikov, G. V., Enama, M. E., Sarwar, U., Larkin, B., and Graham, B. S., DNA Priming for Seasonal Influenza Vaccine: a Phase 1b Double-Blind Randomized Clinical Trial, PLoS One, vol. 10, no. 5, p. e0125914, 2015.
D. I. Bernstein, Edwards, K. M., Dekker, C. L., Belshe, R., Talbot, H. K., Graham, I. L., Noah, D. L., He, F., and Hill, H., Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults, J Infec Dis, vol. 197, pp. 667-675, 2008.
R. B. Belshe, Mendelman, P. M., Treanor, J., King, J., Gruber, W., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., Iacuzio, I., and Wolff, M. C., The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children, N Engl J Med, vol. 338, pp. 1405-12, 1998.
R. B. Belshe, Gruber, W., Mendelman, P. M., Cho, I., Reisinger, K., Block, S., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., King, J., Kotloff, K., Bernstein, D. I., Hayden, F. G., Zangwill, K., Yan, L., and Wolff, M. C., Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine, J Pediatric, vol. 136, pp. 168-175, 2000.
R. B. Belshe, Leone, P. A., Bernstein, D. I., Wald, A., Levin, M., Stapleton, J. T., Gorfinkel, I., Morrow, R. L., Ewell, M. G., Stokes-Riner, A., Dubin, G., Heineman, T. C., Schulte, J. M., and Deal, C. D., Efficacy Results of A Trial of A Herpes Simplex Vaccine, N Engl J Med, vol. 366, no. 1, pp. 34-43, 2012.
D. I. Bernstein, Bellamy, A. R., Hook, E. W. 3rd, Levin, M. J., Wald, A., Ewell, M. G., Wolff, P. A., Deal, C. D., Heineman, T. C., Dubin, G., and Belshe, R. B., Epidemiology, Clinical Presentation, and Antibody Response to Primary Infection With Herpes Simplex Virus Type 1 and Type 2 in Young Women, Clin Infect Dis, vol. 56, pp. 344-351, 2013.
J. M. Schulte, Bellamy, A. R., Hook, E. W., Bernstein, D. I., Levin, M. J., Leone, P. A., Sokol-Anderson, M., Ewell, M., Wolff, P. A., Heineman, T. C., and Belshe, R. B., HSV-1 and HSV-2 Seroprevalence in the United States Among Asymptomatic Women Unaware of any Herpes Simplex Virus Infection (Herpevac Trial for Women), Southern Medical Journal, vol. 107, pp. 79-84, 2014.
D. I. Bernstein, Jackson, L., Patel, S. M., Sahly, H. M., Spearman, P., Rouphael, N., Jr., T. L. Rudge, Hill, H., and Goll, J. B., Immunogenicity and Safety of Four Different Dosing Regimens of Anthrax Vaccine Adsorbed for Post-Exposure Prophylaxis for Anthrax in Adults, Vaccine, vol. 32, pp. 6284-6293, 2014.
R. L. Atmar, Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., and Mendelman, P. M., Norovirus Vaccine Against Experimental Human Norwalk Virus Illness, N Engl J Med, vol. 365, pp. 2178-2187, 2011.
T. C. Heineman, Schleiss, M., Bernstein, D. I., Spaete, R. R., Yan, L., Duke, G., Prichard, M., Wanh, Z., Yan, Q., Sharp, M. A., Klein, N., Arvin, A. M., and Kemble, G., A Phase I Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimeric Vaccines, J Infec Dis, vol. 193, pp. 1350-1360, 2006.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. E., Rouphael, N. G., Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, Vaccine, vol. 33, pp. 163-173, 2015.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, J Infect Dis, vol. 206, pp. 828-837, 2012.
N. B. Halasa, Gerber, M. A., Berry, A. A., Anderson, E. L., Winokur, P., Keyserling, H., Eckard, A. R., Hill, H., Wolff, M. C., McNeal, M. M., Edwards, K. M., and Bernstein, D. I., Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age, J Pediatric Infect Dis Soc, vol. 4, no. 3, pp. 214-224, 2015.
M. J. Mulligan, Bernstein, D. I., Winokur, P., Rupp, R., Anderson, E., Rouphael, N., Dickey, M., Stapleton, J. T., Edupuganti, S., Spearman, P., Ince, D., Noah, D. L., Hill, H., and Bellamy, A. R., Serological Responses to an Avian Influenza A/H7N9 Vaccine Mixed at the Point-of-Use with MF59 Adjuvant: A Randomized Clinical Trial, JAMA, vol. 312, pp. 1409-1419, 2014.
T. Talbot, Stapleton, J. T., Brady, R. C., Winokur, P. L., Bernstein, D. I., Germanson, T., Yoder, S., Rock, M. T., Crowe, J. E., and Edwards, K. M., Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine, J Amer Med Assn, vol. 292, pp. 1205-1212, 2004.